DarioHealth (DRIO) Short-term Investments (2012 - 2026)

DarioHealth (DRIO) has reported Short-term Investments for 15 consecutive years, with $7.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments rose 3261.01% year-over-year to $7.3 million; the trailing twelve-month figure through Jun 2026 stood at $7.3 million (up 3261.01% YoY), and the FY2025 full-year result was $4.2 million, up 504.59% from the prior year.
• Short-term Investments improved to $7.3 million in Q2 2026 per DRIO's latest filing, from $5.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $7.3 million in Q2 2026 and bottomed at $165000.0 in Q4 2022.
• Historically, Short-term Investments has averaged $1.5 million across 5 years, with a median of $394000.0 in 2023.
• The sharpest annual moves came in 2025 and 2026: Short-term Investments tumbled 80.23% in 2025, then soared 3261.01% in 2026.
• Over 5 years, Short-term Investments stood at $165000.0 in 2022, then jumped by 76.97% to $292000.0 in 2023, then jumped by 138.7% to $697000.0 in 2024, then surged by 504.59% to $4.2 million in 2025, then jumped by 73.87% to $7.3 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $7.3 million, $5.0 million, and $4.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.